MSD wins patent extension feud over post-surgery drug
15-06-2023
MSD prevails in diabetes drug dispute with Mylan
29-09-2022
MSD targets Mankind’s diabetes generic in patent suit
05-04-2022
MSD, Pfizer try to stop three Steglatro generics
29-03-2022
Ono sues AstraZeneca over antibody patents
01-03-2022
Judge partially revives California pay-for-delay ban
17-02-2022
AstraZeneca aims to stifle Mylan’s revived shot at generic inhaler
27-01-2022
AstraZeneca inks $730m licensing deal for rare heart disease treatment
11-01-2022